Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine

Trial Profile

Perindopril arginine/Amlodipine versus Valsartan/Amlodipine antihypertensive strategies: Efficacy and safety in mild to moderate hypertensive patients. A randomised, double blind 6-month study followed by 8-month open label long-term follow-up with Perindopril arginine/Amlodipine

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2016

At a glance

  • Drugs Perindopril/amlodipine (Primary) ; Amlodipine/valsartan; Indapamide; Valsartan
  • Indications Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors IRIS
  • Most Recent Events

    • 15 Jun 2015 Results of clinical trial program (4 studies) presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 01 Sep 2012 Actual end date (1 Sep 2012) added as reported by ISRCTN: Current Controlled Trials.
    • 01 Sep 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top